Join attorneys from Womble Bond Dickinson (US) LLP for a discussion about regulatory and intellectual property considerations in the life sciences arena. As part of the lunch and learn, we will discuss:
 

• Licensing of proprietary information for drugs and biologics through FDA Master Files and related regulatory issues;
  
  
• Collaboration agreements and data privacy
  
  
• When does the clock start ticking for filing a patent (and what counts as a public disclosure)

In addition to our 30-minute presentation, we will have attorneys on hand to address issues involving data privacy and cybersecurity, trademark registration, and intellectual property litigation.